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Abstract: The common brushtail possum (Trichosurus vulpecula), introduced from Australia in the
mid-nineteenth century, is an invasive species in New Zealand where it is widespread and forms the
largest self-sustained reservoir of bovine tuberculosis (Mycobacterium bovis) among wild populations.
Conservation and agricultural authorities regularly apply a series of population control measures to
suppress brushtail possum populations. The evolutionary consequence of more than half a century
of intensive population control operations on the species’ genomic diversity and population structure
is hindered by a paucity of available genomic resources. This study is the first to characterise the
functional content and diversity of brushtail possum liver and brain cerebral cortex transcriptomes.
Raw sequences from hepatic cells and cerebral cortex were assembled into 58,001 and 64,735 transcripts
respectively. Functional annotation and polymorphism assignment of the assembled transcripts
demonstrated a considerable level of variation in the core metabolic pathways that represent potential
targets for selection pressure exerted by chemical toxicants. This study suggests that the brushtail
possum population in New Zealand harbours considerable variation in metabolic pathways that
could potentially promote the development of tolerance against chemical toxicants.
Keywords: De novo transcriptome assembly; common brushtail possum; liver; brain cerebral cortex;
drug and xenobiotic metabolism; chemical toxicants
1. Introduction
New Zealand separated from other landmasses approximately 85 million years ago and has
remained largely isolated ever since [1]. Ecological isolation created distinctive evolutionary dynamics
in the archipelago rarely seen elsewhere on the planet. By the time the first humans colonised
in approximately 1300 AD [2,3], no native land mammals, other than three species of bats, were
present [4]. The negative impacts of two consecutive waves of human colonisation triggered a series of
fundamental alterations in the biological diversity of New Zealand. The introduction of three species
of rats (Rattus spp.), three species of mustelids (Mustela spp.), and the common brushtail possum
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(Trichosurus vulpecula), in combination with extensive human hunting and habitat destruction, triggered
a spiral of catastrophic events that drove fifty-nine bird species extinct and severely threatens the
survival of other native species, including endemic marine mammals, native bat species, frogs, and
much of the invertebrate fauna [5,6].
The common brushtail possum (hereafter ‘brushtail possum’) was introduced into New Zealand
from localities in Tasmania and the eastern Australian mainland in the 1850s to establish a profitable
fur industry [7,8]. Soon after its introduction, the species established itself in the wild, proliferated,
and spread across all habitats in the archipelago. In these new habitats, brushtail possums reached
population densities far exceeding those in their native Australian range [4]. The phenomenal success
of brushtail possums in New Zealand has been linked to the high abundance of palatable and nutritious
food sources, and the presence of fewer parasites, predators, and competitors [9]. The scale of
devastation upon New Zealand’s endemic ecosystems prompted the brushtail possum’s designation
as both an agricultural pest and a major threat to New Zealand’s unique flora and fauna [9,10].
Wild populations of brushtail possums also harbour a self-sustained reservoir of bovine tuberculosis
(Mycobacterium bovis) that threatens New Zealand’s dairy and livestock industries [4]. As a result, the
brushtail possum has been subject to decades of targeted population control operations.
Conservation and agricultural authorities in New Zealand regularly apply a series of population
eradication and control measures to mitigate the negative impacts of brushtail possums on native
ecosystems. Since 1957, aerial dispersal of cereal baits containing the chemical toxicant sodium
fluoroacetate (or ‘compound 1080′) has constituted the cornerstone of management plans to control
brushtail possums and other invasive mammals in New Zealand [10,11]. Synthetic compound 1080 is
a water-soluble salt modelled on the naturally occurring plant toxin fluoroacetate [12]. Several plant
species across the globe, such as Gastrolobium spp. and Oxyylobium spp., use this toxicant as a deterrent
against herbivory, including species within the possum’s native Australian home range [13–15].
Brushtail possum populations in New Zealand face a combination of stressors and human-induced
selection pressures that differ from those in their native Australia. The speed of local adaptation typically
found in many invasive species suggests that the genetic recipe for adaptation predominately arises
from standing genetic variations present in the founder populations [16,17]. Triggs and Green [18] and
Sarre et al. [19] reported that current populations of the brushtail possum in New Zealand originated
from two distinct subspecies, Trichosurus vulpecula fuliginosus from Tasmania and T. vulpecula vulpecula
from mainland Australia, and that extensive hybridisation took place following their introduction to
New Zealand. Genetic variations among the founder populations propagated in the non-native range
and most likely became reshuffled into new genotypes that do not occur in Australia.
Recent advances in DNA sequencing technology and high-performance computing have facilitated
the comprehensive study of functional regions in eukaryote genomes. Variability in the genome has
made it possible to address some fundamental questions in evolutionary genetics, such as the prediction
of pathways associated with fruit colour [20], intraspecific variation in morphology and behaviour [21],
susceptibility to pathogens [22–25], responses to chemicals [23], adaptation to environmental
changes [26], species diagnostics markers in endangered shrimps [27], sex determination [28], and
changes in the expression profiles of an organ during embryonic development [29].
Understanding the brushtail possum’s evolutionary dynamics in New Zealand is hindered by a
paucity of available genomic resources for this species [30]. In particular, the evolutionary consequences
of more than half a century of intensive population control measures on its genetic diversity and
population structure merit in-depth investigation. To address these fundamental questions, genomic
resources are required.
In the current study, we characterise the functional content and genetic diversity of brushtail
possum liver and brain cerebral cortex transcriptomes, tissues of major importance in responding to
chemical toxicants and in modulating complex behaviour [31–34]. The core metabolic pathways in
these tissue types are among the primary targets of selective pressures imposed by anthropogenic
chemicals [35–37]. This study serves as a stepping-stone for a better understanding of the brushtail
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possum’s evolutionary dynamics in New Zealand and will contribute towards the optimisation
of a comprehensive population management plan for the species, in line with the New Zealand
Predator-Free 2050 horizon objectives.
2. Materials and Methods
2.1. Animal Ethics Statement
Animal ethics approval for this study was obtained from the Lincoln University Animal Ethics
Committee (AEC 586). Approved standard operation procedures were used for both animal husbandry
and euthanasia. All necessary steps were taken to minimise the pain and suffering of the subject animals.
2.2. Specimen Collection
In total, four brushtail possums (two males and two females) were live trapped on the east
and west coasts of New Zealand’s two main islands (Banks Peninsula and Buller, South Island, and
Taranaki and Hawkes Bay, North Island). The animals were transferred to the wild animal husbandry
facilities (Johnstone Memorial Laboratory) at Lincoln University. On the day of specimen collection, sex,
weight, and health status of each animal were recorded by Lincoln University’s wildlife animal facility
staff. The brushtail possums were humanely euthanised by intracardiac administration of 300 mg of
Pentobarbital. The dissection and collection of the liver and cerebral cortex biopsies were performed
after the death of the animals was confirmed on site. Approximately 1 mm3 tissue from liver and brain
cerebral cortex were excised, transferred to 10:1 volume of RNAlater solution (Qiagen-Hilden) and
stored at −80 ◦C until RNA was extracted within one week after specimen collection. Liver cells are
assumed to be more homogeneous in their gene expression profiles, but see Reference [38], whereas
brain cell expression profiles often differ considerably between different brain regions [39,40]. To
account for variations in the gene expression profiles in the possums’ cerebral cortex, brain biopsies
from three individuals were excised from different sections of the proximal cerebral cortex in the left
and right cortical lobes. The remaining biopsy was taken from deeper white matter in the cerebral
cortex. A wildlife histologist examined all brain biopsies to validate their origin.
2.3. Nucleic Acid Extraction, Genomic Library Preparation, and Sequencing
Total RNA was purified from liver and brain tissue using Qiagen’s RNeasy Mini Kit (Hilden,
Germany). The extracted RNA was eluted in 50–100 µl of water. The quality of the purified RNA was
measured using Agilent’s Bioanalyzer (Santa Clara, United States) to obtain an RNA Integration Number
score before proceeding with complementary DNA preparation. Nugen’s Ovation RNA-Sequencing
System (Redwood City, United States), automated on an Apollo324 liquid handler (Takara Bio, Kyoto,
Japan), was used to create complementary DNA using a single primer isothermal amplification method
and 100 ng of template RNA. The resulting complementary DNA was quantified on a Nanodrop
spectrophotometer (ThermoFisher Scientific, Massachusetts, United States) and sheared to 200 bp
fragments using the Covaris M220 ultrasonicator (Woburn, Unites States). Illumina-compatible
sequencing libraries were prepared using KAPA Biosystem’s LTP library preparation kit (Pleasanton,
United States). Individual sequencing adapters with sample-specific barcodes (Bioo Scientific, Austin,
United States) were ligated to the end-repaired fragments, the resulting libraries were cleaned using
AMPure beads (Beckman-Coulter, Brea, United States) and amplified for ten PCR cycles with KAPA’s
HiFi polymerase. The concentration of each library was quantified separately using qPCR on the
Quantstudio 5 (Applied Biosystems, Foster City, United States) and the fragment sizes were verified
using the Agilent Bioanalyzer. All sequencing libraries were normalised to 2 nM concentration before
pooling for multiplex sequencing on two 1 × 50 flow cells on an Illumina HiSeq2000 platform (San
Diego, United States) at the Arizona State University genomics core facility.
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2.4. Transcriptome Assembly, Variant Calling and Functional Annotation
Leading and trailing low-quality or N bases (Phred quality below three), all base pairs with average
Phred score < 20, and Illumina adapter contaminations were removed using Trimmomatic v0.39 [41].
A reference transcriptome for each tissue type was assembled de novo in Trinity v2.8.6 (Inchworm,
Chrysalis, and Butterfly modules) [42] using default settings. Resulted transcripts were clustered into
unique clusters by utilising cd-hit-est from the CD-HIT v4.7 package and setting identity parameters to
98% [43]. The longest reading frame within each transcript was predicted in TransDecoder v5.5.0 [44].
All transcripts were functionally annotated using the Trinotate pipeline [45]. In Trinotate, all transcripts
were searched against known proteins and core metabolic pathways deposited in Swiss-Prot protein
(https://www.uniprot.org/), NCBI non-redundant protein (https://www.ncbi.nlm.nih.gov/refseq/), and
Kyoto Encyclopaedia of Genes and Genomes (KEGG) (https://www.genome.jp/kegg/) databases.
In addition, the protein domains for all transcripts were predicted in HMMER v3.1 [46] based on
the similarity to the known proteins in the Pfam (https://pfam.xfam.org/) database. Transmembrane
proteins and ribosomal RNA were separately identified using TmHMM v2 [47] and RNAMMER
v1.2 [48], respectively. The Benchmarking Universal Single-Copy Orthologs (BUSCO V3) pipeline [49]
was executed in protein mode to evaluate the completeness of the gene content of the reference
transcriptome of each tissue compared to the core mammalian gene content (Mammalia-0db-10, created
on 2019-11-20).
From all specimens, quality-filtered sequences were aligned against the corresponding assembled
transcriptome using Bowtie2 [50], BWA-ALN [51], and BWA-MEM aligners [52] and mapping statistics
from each alignment file were estimated separately in SAMtools v1.9 flagstat script [53].
A combination of SAMtools v1.9 mpileup command [53] and Varscan2 v2.3.7 [54] were used to
identify single nucleotide polymorphic sites (SNPs) in each tissue type. Default settings were used for
variant calling, an exception being the p-values in Varscan2, which were lowered to 0.001 to increase
prediction accuracy. Functional impacts of the polymorphic sites on protein sequences were predicted
using the KisSplice2reftranscriptome v1.3.3 pipeline [55].
Two datasets were created and investigated in parallel to unravel variability in the functional
content of each tissue type. The first consisted of ten transcripts within each tissue’s reference
transcriptome that showed the highest number of polymorphic sites, as reported in the Varscan2
output files. In the second dataset, the abundance of each transcript was estimated in RSEM v1.3.1 [56],
and 5% of the transcripts with the highest normalised level of expression (estimated as per million
mapped reads, TPM) were sub-selected for further functional analysis.
The enrichments of the ten most polymorphic transcripts in each tissue type, for particular
biological functions in terms of Gene Ontology categories (GO terms) [57], were investigated using the
g: Profiler online server [58] and the annotated genome of the grey short-tailed opossum, Monodelphis
domestica, was used as the closest high-quality annotated gene set.
The tissue-specific expression profiles and intra-individual variations in the functional content of
polymorphic sites were statistically tested using the WEGO v2.0 online tool [59] and visualised using a
combination of the REVIGO online server [60] and CirGO [61]. The signal of pervasive selection (the
ratio of non-synonymous to synonymous amino acid substitution, dN/dS ratio) in one particular liver
transcript with an exceptionally high number of polymorphic sites was tested using a fixed-effects
likelihood model [62] implemented in the online server Datamonkey [63].
The functional content of the assembled transcripts and two generated datasets, in terms of core
metabolic pathways, was reconstructed by mapping transcripts against the KEGG database using the
KEGG mapper online server [64] and results were summarized in GAEV [65].
3. Results
The histological reports confirmed that three of the brain cerebral cortex biopsies originated from
the proximal cortex, while the remainder originated from deeper within the cerebral cortex white
matter (Supplementary Materials Figures S1–S4).
Genes 2020, 11, 436 5 of 18
The RNA sequencing run yielded 183,517,606 and 178,725,338 raw sequences from liver and brain
cerebral cortex, respectively. Liver tissue sequences were assembled into 58,001 transcripts (candidate
genes and isoforms), with a mean contig length of 813.37 and a GC content of 42.57%. From the cerebral
cortex brain tissue, Trinity assembled sequences with a total of 64,735 transcripts, a mean contig length
of 738.13, and a GC content of 42.68% (Table 1). CDHIT subsumed all transcripts into 57,221 and 63,679
unique clusters with more than 98% sequence identity for liver and brain cerebral cortex, respectively.
Table 1. Summary statistics of the reference transcriptome assembly of the New Zealand brushtail
possum’s liver and brain cerebral cortex tissue as estimated in QUAST v.4.0 [66].
Assembly Name Liver Cells Brain Cells
Number of contigs 58,001 64,735
Number of contigs ≥ 1000 bp 13,361 12,385
Number of contigs ≥ 5000 bp 605 612
Number of contigs ≥ 10,000 bp 19 24
Total length bp 47,176,165 47,783,051
Total length ≥ 1000 bp 29,238,918 27,088,346
Total length ≥ 5000 bp 3,994,586 4,080,570
Total length ≥ 10,000 bp 245,362 318,579
Largest contig 18,159 21,422





The semi-global BWA-MEM aligner performed better, in terms of mapping quality and percentage
of aligned sequences, compared to two other aligners, and was selected for downstream analysis.
The overall alignment rate was estimated at 90.93% for liver sequences and 79.80% for brain cerebral
cortex sequences. The alignment rate in both tissue types lies within the recommended range in the
Trinity pipeline for a complete reference transcriptome assembly (https://github.com/trinityrnaseq/
trinityrnaseq/wiki/RNA-Seq-Read-Representation-by-Trinity-Assembly). From a total of 9226 searched
BUSCOs, 3290 and 2446 of the core mammalian’s complete BUSCOs were identified in the hepatic and
brain cerebral cortex transcriptomes, respectively (Supplementary Materials Table S1). Tissue-specific
transcriptomes, especially in non-model organisms, are very unlikely to produce complete mammalian
BUSCOs and that should be interpreted within the biological context of the study, rather than as a
direct metric for estimating the completeness of the assembled transcriptomes.
Varscan2 identified 35,300 (one SNP for every 1339 bp) and 23,805 (one SNP for every 2007 bp)
variable sites in liver and brain cerebral cortex transcripts, respectively. The number of polymorphic
sites with transitions was estimated to be three times higher than the number of transversions in
both tissue types. The polymorphism landscape in brushtail possum cerebral cortex was more
heterogeneous compared to hepatic cells. Only 25% (5939 out of 23,805) of the polymorphic sites in
cerebral cortex tissues were successfully genotyped across all four sampled tissues compared to 70%
shared polymorphisms (24,924 out of 35,225) among hepatic tissues.
KisSplice identified 34,329 (22,887 synonymous and 11,442 synonymous) and 4695 (3244
synonymous and 1451 non-synonymous) codon substitutions in hepatic and cerebral cortex tissues,
respectively. The reported high levels of heterogeneity in gene expression profiles among different
sections of the cerebral cortex provide the most likely explanation for the observed pattern of
codon substitutions.
In the hepatic cells, non-synonymous mutations of the codons GTT to ATT, ACG to ATG
(substitution of amino acid valine to isoleucine) and GTC to ATC (substitution of amino acid threonine
to methionine) had the highest frequency. In the brain cerebral cortex, non-synonymous mutation
of the codons GTG to CTG (substitution of amino acid valine to leucine) AAA to AGA (substitution
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of amino acid lysin to arginine) and AGT to AAT (substitution of amino acid serine to asparagine)
were prevalent. The highest rate of synonymous amino acid substitutions was observed for aspartate
(mutation in codon GAC to GAT or GAT to GAC) and asparagine (mutations in the codon AAC to
AAT) in the hepatic cells and for amino acids aspartate (mutation in the codon GAC to GAT) and
proline (mutation in the codon CCA to CCG) in the brain cortical cells (Supplementary Materials Tables
S4 and S5)
A transcript in the liver was of particular interest because of an exceptionally large number of
polymorphic sites (127 SNPs). The BLASTX search of this transcript showed high sequence identity
(88% similarity) to various isoforms of multidrug resistance proteins reported in koala, Phascolarctos
cinereus (NCBI reference XP_020843128.1), and common wombat, Vombatus ursinus (NCBI Reference
Sequence: XP_027703707.1). In all four brushtail possums, alignment of the protein-coding sequences
of this transcript demonstrated 19 candidate sites that were under pervasive purifying selection
(dN/dS < 1, p-value < 0.05). The majority of the non-synonymous amino acid substitutions in these
transcripts (6 out of 30) were in the form of valine to isoleucine substitutions. The synonymous
substitution for amino acids alanine and isoleucine (11 out of 45) constituted a considerable number of
substitution patterns in the same transcript.
Searching all assembled transcripts against multiple databases showed a considerable number of
uncharacterised transcripts within both tissue types (Supplementary Materials Figures S5 and S6).
The analysis of the functional content of both transcriptomes in terms of Gene Ontology (GO)
illustrated that GO terms associated with biochemical pathways involved in cellular components
(cells, organelle and organelle parts, membrane, and extracellular regions), molecular functions
(catalytic activity, binding, molecular function regulators, and molecular transducer activity), and
biological processes (response to stimulus, cellular process, biological regulation, metabolic process,
and biogenesis) dominated the functional diversity of both tissue types ( Figure 1; Figure 2).
The hepatic cells were more homogeneous in their gene ontology profiles across individuals.
Only two metabolic pathways involved in the biological process, anatomical structure developments
and multicellular organism developments, showed statistically significant differences in the number
of associated polymorphic sites (2 test p-value < 0.05) across the four individuals (Figure 3). The
brain biopsies taken from different sections of the cerebral cortex demonstrated more heterogenous
profiles in their polymorphism landscape. Twelve metabolic pathways involved in cellular components
(neurone part, extracellular organelle-complex, and extracellular space), molecular functions (catalytic,
hydrolase, transferase, and protein-binding activities), and a biological process linked to transposition
showed a significant level of variation across different parts of the cerebral cortex (2 test p-value < 0.05)
(Figure 4).
Comparing the liver and brain datasets consisting of the ten most polymorphic sites against the
closely related grey short-tailed opossum illustrated significant enrichment for various metabolic
pathways (Figure 5; Figure 6).
The dataset of 5% highly expressed transcripts illustrated that the expression profile between two
tissue types differs significantly (2 test p-value < 0.05) in the metabolic pathways linked to 58 GO terms
(Supplementary Materials Figure S7).
The metabolic pathways analysis of the transcripts against the KEGG database indicated that the
liver transcriptome was linked to 394 core metabolic pathways and 23 complete metabolic modules.
Brain cerebral cortex transcriptome was involved in 379 core metabolic pathways and eight complete
metabolic modules (Supplementary Materials Tables S2 and S3).
In the liver tissue, the most polymorphic transcripts were involved in eight KEGG metabolic
pathways including lipid metabolism, nucleotide metabolism, amino acid metabolism, cofactor and
vitamin metabolism, xenobiotics biodegradation and metabolism, and the endocrine system. Mapping
the ten most polymorphic transcripts in the brain cerebral cortex against the KEGG database indicated
their involvement in 14 core biological pathways, including core metabolic pathways, biosynthesis of
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secondary metabolites, metabolism of cofactors and vitamins, signal transduction, signalling molecules
and interaction, transport and catabolism, the cellular community, and the excretory system.
Figure 1. Functional annotation of all polymorphic transcripts in brushtail possum liver cells based
on Gene Ontology (GO) categorisation. The X-axis indicates GO functions and the Y-axis shows the
percentage of transcripts in log (10) scales.
Figure 2. Functional annotation of all polymorphic transcripts in brushtail possum brain cerebral cortex
cells based on Gene Ontology (GO) categorisation. The X-axis indicates GO functions and the Y-axis
shows the percentage of transcripts in log (10) scales.
Figure 3. Intra-individual variation in the functional content of polymorphic transcripts in brushtail
possum liver cells based on Gene Ontology (GO) categorisation. The X-axis indicates GO functions and
the Y-axis shows the percentage of transcripts.
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Figure 4. Intra-individual variation in the functional content of polymorphic transcripts in brushtail
possum cerebral cortex cells based on Gene Ontology (GO) categorisation. The X-axis indicates GO
functions and the Y-axis shows the percentage of transcripts.
Figure 5. Functional enrichment of 10 transcripts with the highest levels of polymorphism, based on
Gene Ontology (GO) categorisation, in brushtail possum liver cells compared to the grey short-tailed
opossum (Monodelphis domestica) complete gene set.
The dataset consisting of 5% of the most abundant transcripts of hepatic cells was linked to 354
biological pathways and eight complete metabolic modules (Table 2). The highly expressed transcripts
in the brain cerebral cortex were associated with 342 biological pathways and four complete metabolic
modules (Table 3). A total of 22 genes in the liver transcriptomes and ninegenes in the cerebral
cortex were directly linked to the metabolic pathways that involved drug and xenobiotic substances
metabolism (Table 4; Table 5).
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Figure 6. Functional enrichment of 10 transcripts with the highest levels of polymorphism, based on
Gene Ontology (GO) categorisation, in brushtail possum cerebral cortex cells compared to the grey
short-tailed opossum (Monodelphis domestica) complete gene set.
Table 2. Kyoto Encyclopaedia of Genes and Genomes (KEGG) metabolic pathway names and number
of instances identified in the top 5% of the highly expressed genes within the brushtail possum
liver transcriptome.
Metabolic Pathway Number





Amino acid metabolism 152
Metabolism of other amino acids 25
Glycan biosynthesis and metabolism 17
Metabolism of cofactors and vitamins 54
Metabolism of terpenoids and polyketides 10
Biosynthesis of other secondary metabolites 12
Xenobiotics biodegradation and metabolism 60
Transcription 8
Translation 98
Folding, sorting, and degradation 70
Replication and repair 3
Membrane transport 5
Signal transduction 228
Signalling molecules and interaction 35
Transport and catabolism 116














Development and regeneration 21
Aging 23
Environmental adaptation 49
Table 3. Kyoto Encyclopaedia of Genes and Genomes (KEGG) metabolic pathway names and number
of instances identified in the top 5% of the highly expressed genes within the brushtail possum cerebral
cortex transcriptome.
Metabolic Pathway Number





Amino acid metabolism 51
Metabolism of other amino acids 6
Glycan biosynthesis and metabolism 10
Metabolism of cofactors and vitamins 9
Metabolism of terpenoids and polyketides 5
Biosynthesis of other secondary metabolites 6
Xenobiotics biodegradation and metabolism 10
Transcription 14
Translation 104
Folding, sorting and degradation 61
Replication and repair 6
Membrane transport 1
Signal transduction 442
Signaling molecules and interaction 39
Transport and catabolism 128
Cell growth and death 100
Cellular community - eukaryotes 79









Development and regeneration 44
Aging 26
Environmental adaptation 68
Table 4. Name and description of the putative genes involved in drug and xenobiotic substance
metabolic pathways in brushtail possum liver cells as predicted using the KEGG database.
Gene Name Description
frmA, ADH5, adhC S-(hydroxymethyl)glutathione dehydrogenase/alcohol dehydrogenase
AOX aldehyde oxidase
DPYD dihydropyrimidine dehydrogenase (NADP+)
MAO, aofH monoamine oxidase
FMO dimethylaniline monooxygenase (N-oxide forming)




GST, gst glutathione S-transferase
ndk, NME nucleoside-diphosphate kinase
CES1 carboxylesterase 1
DPYS, dht, hydA dihydropyrimidinase
dut, DUT dUTP pyrophosphatase
PIK3R1_2_3 phosphoinositide-3-kinase regulatory subunit α/β/delta
CES2 carboxylesterase 2
CYP1A2 cytochrome P450 family 1 subfamily A polypeptide 2
CYP2E1 cytochrome P450 family 2 subfamily E polypeptide 1
GSTK1 glutathione S-transferase kappa 1
ADH1_7 alcohol dehydrogenase 1/7
CYP3A4 cytochrome P450 family 3 subfamily A polypeptide 4
CYP3A5 cytochrome P450 family 3 subfamily A polypeptide 5
CYP2B6 cytochrome P450 family 2 subfamily B polypeptide 6
CYP2C8 cytochrome P450 family 2 subfamily C polypeptide 8
CYP2C19 cytochrome P450 family 2 subfamily C polypeptide 19
Table 5. Name and description of the putative genes involved in drug and xenobiotic metabolic
pathways in brushtail possum brain cerebral cortex cells as predicted using the KEGG database.
Gene Name Description
CBR1 carbonyl reductase 1
hprT, hpt, HPRT1 hypoxanthine phosphoribosyltransferase
GST, gst glutathione S-transferase
ndk, NME nucleoside-diphosphate kinase
dut, DUT dUTP pyrophosphatase
PIK3R1_2_3 phosphoinositide-3-kinase regulatory subunit
α/β/delta
TOP2 DNA topoisomerase II
ERK, MAPK1_3 mitogen-activated protein kinase 1/3
AKT RAC serine/threonine-protein kinase
4. Discussion
The potential of pests, pathogens, and invasive species to evade conventional population
control measures represents a major threat across the globe [67]. Resistance against antibiotics and
anthropogenic toxicants occurs in all domains of life, from bacteria to arthropods and vertebrates [68–72].
The genomic basis of developing resistance in non-rodent vertebrates continues to be underrepresented
in research and suffers from a lack of functional genomic studies. The current study is the first to
characterise the functional content and diversity of the liver and brain cerebral cortex transcriptomes
of a non-rodent mammalian pest, the marsupial common brushtail possum, in New Zealand.
The functional content and polymorphism landscape of liver and brain cerebral cortex
transcriptomes in brushtail possums are involved in a diverse array of biological processes. The
functional content of these tissue types plays a critical part in the detoxification of xenobiotic
substances [73,74] and modulation of complex behaviours [75,76] that potentially promote the
development of physiological and behavioural tolerance against chemical compounds.
Enzymes produced from cytochrome P450 gene groups (such as CYP1A2, CYP2E1, CYP3A4,
CYP3A5, CYP2B6, CYP2C8, and CYP2C19) dominate the biochemical pathways involved in drug and
xenobiotic substance metabolism in brushtail possum hepatic cells. Polymorphisms in this group of
heme-containing proteins influence the speed and efficiency of chemical compound breakdown in the
liver and other organs [77,78]. Similarly, the CYP2C group of genes has been reported to show high
levels of expression in liver tissues of the herbivorous koala (Phascolarctos cinereus) [79].
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The detoxification of the harmful component of compound 1080, fluoroacetate, takes place in the
hepatocytes [14,80–82]. Polymorphism in the liver transcripts for the metabolic pathways involved in
response to drugs and xenobiotic substances is not unexpected. Nonetheless, an exceptionally high
number of polymorphic sites associated with these pathways, particularly a contig with high similarity
to the multidrug resistance protein family reported from other marsupials, suggest the potential of
standing genomic variation within New Zealand populations that may allow alternative responses to
population control chemicals.
Multidrug resistance proteins confer increased drug resistance through a decrease in drug
accumulations resulting from increased drug efflux [83,84]. Members of this ATP-binding cassette
protein super-family function as active transporters of various organic substances, anionic conjugates,
and xenobiotic substances, including glutathione, glucuronide, and sulfate conjugates [85,86]. Metabolic
pathways that involve glutathione and a unique glutathione transferase are closely linked to the
detoxification of compound 1080 and other similar-acting toxicants in hepatic cells [14,80–82]. Moreover,
the estimated ratio of synonymous to non-synonymous amino acid substitutions in this transcript
indicates that parts of the multi-drug resistance metabolic pathways in brushtail possum hepatic
cells may be subject to a significant level of purifying selection against less beneficial genotypes. The
pre-adaptations of founder populations with natural exposure to this toxicant in Australia, and the
fitness implication of the observed evolutionary dynamics, are yet to be fully understood and require
comparative functional genomic studies between a larger sample of brushtail possums in their native
range in Australia and invaded habitat in New Zealand.
In the current study, several enriched metabolic pathways were identified in the brushtail possum
cerebral cortex transcriptome that regulate a wide range of core neurobiological processes, such as
organic substance transport, response and regulation of biological processes, cell communications,
neurochemical signalling, and locomotion. The biochemical pathways involved in drug and xenobiotic
substance metabolism in the cerebral cortex are largely different from those identified in liver cells.
The products of several genes in the brushtail possum cerebral cortex (Table 5) are associated with
the development of resistance against platinum-based anti-malignancy drugs in humans. The
complex dynamics of resistance involve a combination of decreased drug influx, increased drug
efflux, intracellular detoxification by glutathione, decreased binding, increased DNA repair, decreased
mismatch repair, and defective apoptosis [87,88]. However, the physiological significance of these
metabolic pathways in the brushtail possum cerebral cortex in response to the chemicals remains to
be investigated.
The delicate interplay between brain cerebral cortex polymorphisms and modulation of complex
behaviours is an active area of research in neurobiology [89,90]. While addressing these associations
lies beyond the scope of the current study, our results suggest a considerable variation in the
transcriptomic repertoire of thebrushtail possum cerebral cortex that is necessary to modulate complex
behaviours. Ross et al. [91] suggested that a single exposure to a sub-lethal dose of chemical toxicants
in brushtail possums triggers the development of long-lasting bait-shyness behaviours in wild and
captive populations. To what extent bait-shyness represents learned behaviour within an individual
subsequent to sub-lethal exposure, and its heritability across multiple generations, requires more
neurogenomic research.
Instances of developing tolerance against 1080 have already been reported in some wild and
laboratory- populations with natural exposure to fluoroacetate [82], including wild populations
of European rabbit (Oryctolagus cuniculus) in Australia [71], brushtail possums in south-western
Australia [92], and laboratory brown rats (Rattus norvegicus) [93]. The current study did not aim to
identify the development of practical resistance against toxins in New Zealand’s brushtail possum
population. Rather, we demonstrated that these populations harbour considerable levels of functional
variation in the metabolic pathways that could potentially promote the development of tolerance
against chemicals, such as compound 1080 and other similar-acting toxicants. To determine the
sensitivity of the current populations to long-term toxin exposure requires formal toxicology trials
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to measure the lethal concentrations in the laboratory and over time. The power of genetic data to
conclusively predict the development of tolerance against toxins remains limited. The small scale
of this study only allows for some preliminary conclusions that are consistent with what we would
expect to see from a species that has been under intense anthropogenic selection pressures, including
both trapping and toxins, for generations.
As conservation efforts to eradicate invasive mammals intensify towards the objectives of the New
Zealand Predator-Free 2050 horizon, we strongly advocate combined and multifaceted population
control strategies that simultaneously target different aspects of an invasive species’ life history,
behaviour, and physiology in time and space, and thus prevent or delay the potential development
of resistance against any specific population control measure [67,94]. The ecological and economic
impacts of brushtail possums potentially developing tolerance against population control measures
necessitate constant monitoring of current populations and their response to management plans.
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